dinitrofluorobenzene has been researched along with Peritonitis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cheung, PH; Foreman, O; Hain, HS; Kaur, P; Kavirayani, A; Saha, S; Tung, D | 1 |
Babic, AM; Liu, K; Mitchell, HA; Wagner, DD; Wang, HW | 1 |
2 other study(ies) available for dinitrofluorobenzene and Peritonitis
Article | Year |
---|---|
Anti-inflammatory and immunomodulatory effects of bortezomib in various in vivo models.
Topics: Adjuvants, Immunologic; Aminoquinolines; Animals; Anti-Inflammatory Agents; Boronic Acids; Bortezomib; Dinitrofluorobenzene; Disease Models, Animal; Drug Compounding; Drug Evaluation, Preclinical; Drug Stability; Female; Hypersensitivity, Delayed; Imiquimod; Immunologic Factors; Irritants; Male; Mice; Mice, Inbred BALB C; Mice, Inbred ICR; Peritonitis; Psoriasis; Pyrazines; Random Allocation; Temperature; Thioglycolates | 2011 |
Elevated soluble ICAM-1 levels induce immune deficiency and increase adiposity in mice.
Topics: Acquired Immunodeficiency Syndrome; Adiposity; alpha 1-Antitrypsin; Animals; Dermatitis, Contact; Dinitrofluorobenzene; DNA; Globins; Humans; Intercellular Adhesion Molecule-1; Introns; Liver; Macrophages; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neutrophils; Peritonitis; Promoter Regions, Genetic; Solubility; Thioglycolates | 2005 |